Dexamethasone and Markedly reduced food intake - a phase IV clinical study of FDA data

Summary:

Markedly reduced food intake is found among people who take Dexamethasone, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Dexamethasone and have Markedly reduced food intake. It is created by eHealthMe based on reports of 105,970 people who have side effects when taking Dexamethasone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

105,970 people reported to have side effects when taking Dexamethasone.
Among them, 18 people (0.02%) have Markedly reduced food intake.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 106,609 Dexamethasone users for its effectiveness, alternative drugs and more.

What is Markedly reduced food intake?

Markedly reduced food intake is found to be associated with 651 drugs by eHealthMe.

Number of Dexamethasone and Markedly reduced food intake reports submitted per year:

Could Dexamethasone cause Markedly reduced food intake?

Gender of people who have Markedly reduced food intake when taking Dexamethasone *:

female: 44.44 %
male: 55.56 %

Age of people who have Markedly reduced food intake when taking Dexamethasone *:

Common drugs people take besides Dexamethasone *:

Common side effects people have besides Markedly reduced food intake *:

Dehydration (dryness resulting from the removal of water): 8 people, 44.44%
Fever: 7 people, 38.89%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 38.89%
Nausea (feeling of having an urge to vomit): 6 people, 33.33%
Constipation: 4 people, 22.22%
Blood Amylase Increased: 4 people, 22.22%
Abdominal Pain Upper: 3 people, 16.67%
Erythropenia (a deficiency in the number of red blood cells): 2 people, 11.11%
Dizziness Postural: 2 people, 11.11%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and have Markedly reduced food intake?

Check whether Markedly reduced food intake is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

Related studies

How severe was Markedly reduced food intake and when was it recovered:

Markedly reduced food intake in Dexamethasone

Expand to all the drugs that have ingredients of dexamethasone:

Markedly reduced food intake and drugs with ingredients of dexamethasone (49 reports)

Alternative drugs to, pros and cons of Dexamethasone:

Dexamethasone (106,609 reports)

Common Dexamethasone side effects:

Browse all side effects of Dexamethasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Markedly reduced food intake treatments and more:

Markedly reduced food intake (1,545 reports)

COVID vaccines that are related to Markedly reduced food intake:

All the drugs that are associated with Markedly reduced food intake:

Markedly reduced food intake (651 drugs)

All the conditions that are associated with Markedly reduced food intake:

Markedly reduced food intake

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Dexamethasone) and Dexamethasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.